Feng Guo

Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction

Odette A. Fahmi, Susan Hurst, David R. Plowchalk et al. · Drug Metabolism and Disposition · 2009 · 212 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Pasi A. Jänne, David S. Boss, D. Ross Camidge et al. · Clinical Cancer Research · 2011 · 182 citations · Full text

Medicine, Oncology, Pharmacology +17

Autophagy inhibition mediated by MCOLN1/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53/p53 pathway

Yanhong Xing, Xiangqing Wei, Yucheng Liu et al. · Autophagy · 2021 · 142 citations · Full text

Medicine, Cancer Biology, Oncology +17

Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy

Yanhong Xing, Zhongheng Sui, Yucheng Liu et al. · Basic Research in Cardiology · 2022 · 106 citations

Life Sciences, Cardiology, Cell Biology +15

Application of CYP3A4<i>in vitro</i>data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction

Kuresh Youdim, Aref Zayed, Maurice Dickins et al. · British Journal of Clinical Pharmacology · 2008 · 97 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16